Fibrous dysplasia: Differential diagnosis from Paget's disease;Fibröse dysplasie - Morbus Paget: Möglichkeiten der differenzierung

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 43, 2002, Pages 2264-2268

  Wagner, Ph ^a   Heilmann, P ^a   Schulz, A ^b   Nawroth, P ^a   Kasperk, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; PAMIDRONIC ACID;

ADULT; ARTICLE; BONE BIOPSY; BONE PAIN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ETHMOID BONE; FEMALE; FIBROUS DYSPLASIA; GENETIC ANALYSIS; HUMAN; HYPEROSTOSIS; KYPHOSIS; OCCIPITAL BONE; OSTEOPENIA; PAGET BONE DISEASE; SELLA TURCICA; SKELETON MALFORMATION;

EID: 18644383995     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35010     Document Type: Article

References (21)

1. Albright F, Butler AM et al. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females. N Engl J Med 1937; 216: 727-746
2. Bianco P, Riminucci M et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 2000; 15: 120-128
3. Bittner RC, Roßdeutscher R. Leitfaden Radiologie, Indikationen, Befundung - Arbeitstechnik, Differentialdiagnose, 1. Auflage, Stuttgart, New York, Gustav Fischer Verlag, 1996: 610-613
4. Chapurlat RD, Delmas PD et al. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997; 12: 1746-1752
5. Chapurlat RD, Meunier PJ. Bisphosphonates and bone remodeling: Effectiveness in Paget's disease, fibrous dysplasia and osteoporosis. Revue de Chirurgie Orthopedique et Reparatrice de 1 Appareil Moteur 1998
6. Chapurlat RD, Meunier PJ. Fibrous dysplasia of bone. Best Pract Res Clin Rheumatol 2000; 14: 385-398
7. Jr. Cohen MM, Howell RE. Etiology of fibrous dysplasia and McCune-Albright syndrome. Int J Oral Maxillofac Surg 1999; 28: 366-371
8. Del Grande F, Exner GU, Hodler J. Osteofibrous dysplasia and its differential diagnosis. Schweiz Rundsch Medi Prax 1999; 88: 1770-1774
9. Devogelaer JP. Treatment of bone diseases with bisphosphonates, excluding osteoporosis. Curr Opin Rheumatol 2000; 12: 331-335
10. Lala R, Matarazzo P et al. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatrica 2000; 89: 188-193
11. Lane JM, Safdar NK et al. Bisphosphonate therapy in fibrous dysplasia. Clin Orthop 2001; 382: 6-12
12. Mandrioli S, Carinci F et al. Fibrous dysplasia. The clinico-therapeutic picture and new data on ist etiology. A review on literature. Minerva Stomatologica 1998; 47: 37-44
13. McCune DJ. Osteitis fibrosa cystica: The case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyreoidism. Am J Dis Child 1936; 52: 743-747
14. Parisi MS, Oliveri MB, Mautalen CA. Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia. J Clin Densitom 2001; 4: 167-172
15. Pfeilschifter J, Ziegler R. Wirkung von Pamidronat auf beschwerdebild und knochenstoffwechsel bei fibröser dysplasie und Mccune-Albright-syndrom. Med Klinik 1998; 93: 352-359
16. Pinsolle V, Rivel J et al. Treatment of fibrous dysplasia of the cranio-facial bones. Report of 25 cases. Annales de Chirurgie Plastique et Esthetique 1998
17. Seibel MJ, Stracke H. Metabolische Osteopathien: Handbuch für Klinik und Praxis, 1. Auflage, Stuttgart, Schattauer, 1997: 155-156
18. Stanton RP, Hobson GM et al. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia. J Bone Miner Res 1999; 14: 1104-1114
19. Tehranzadeh J, Fung Y et al. Computed tomography of Paget disease ofthe skull versus fibrous dysplasia. Skeletal Radiol 1998; 27: 664-672
20. Weinstein LS, Shenker A et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325: 1688-1695
21. Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 2000; 137: 403-409